KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction ...

The study tested the effects of balcinrenone/dapagliflozin, a combination drug, in different conditions: fasted, fed, and with the P-gp inhibitor quinidine. The goal was to understand how these ...

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of ...

TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt:PF0) a premier artificial intelligence (AI) company transforming ...

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is ...

The announcement of this study could positively influence AstraZeneca’s stock performance and investor sentiment, given the potential for BGF MDI to become a significant treatment option for COPD.

Likewise, Parexel, another of today’s top companies, was founded in 1982, and PPD was founded initially as a one-man consulting company in 19854,5.

The global clinical trial management system market size was US$ 1.4 billion in 2021. The global clinical trial management system market size is forecast to reach US$ 6.1 billion by 2032, growing at a ...

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.